Caricamento...
Impact of High Deductible Insurance on Adjuvant Hormonal Therapy Use in Breast Cancer
OBJECTIVE: High-deductible health plans (HDHP) have become the predominant commercial health insurance arrangement in the United States. HDHPs require substantial out-of-pocket (OOP) costs for most services but often exempt medications from high cost sharing. We examined effects of HDHPs on OOP cost...
Salvato in:
| Pubblicato in: | Breast Cancer Res Treat |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231999/ https://ncbi.nlm.nih.gov/pubmed/29754304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4821-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|